Agricultural supply chain giant Archer-Daniels-Midland (NYSE: ADM) missed Wall Street’s revenue expectations in Q3 2026, but sales rose 9.6% year on year to $22.34 billion. Its non-GAAP profit of $1.77 per share was 10.4% above analysts’ consensus estimates.

Is now the time to buy ADM? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Archer-Daniels-Midland’s third quarter saw sales rise year over year, but the company missed Wall Street’s revenue expectations and the market reacted negatively. Management credited strong biofuels margins in North America and operational improvements in key segments for the quarter’s profit growth. CEO Juan Luciano pointed out, “Our team executed well in a complex operating environment where global energy prices remained elevated and biofuel margins remained favorable.” The company also highlighted progress in its Nutrition business, especially in Flavors and Animal Nutrition, though some areas faced input cost pressures and downtime.

Looking ahead, Archer-Daniels-Midland’s raised non-GAAP earnings guidance is driven by continued strength in biofuels, further operational efficiencies, and targeted investments in automation and growth platforms. Management is cautiously optimistic about maintaining favorable market conditions, but acknowledged ongoing volatility and seasonal factors. Luciano noted, “We see a constructive market structure that actually looks substantially similar to 2026,” signaling expectations for stable demand in core businesses and ongoing investment in technology, R&D, and value-added product lines.

Key insights from management’s remarks

Management attributed the third quarter’s profit growth to biofuels momentum, operational improvements, and segment-specific gains, while highlighting new initiatives and ongoing portfolio adjustments.

• Biofuels margin tailwinds: The company benefited from a favorable North American biofuels environment, supported by strong domestic demand, finalized regulatory policy (RVO), and higher global energy prices. This led to significant profit growth in the Crushing and Refined Products segments.
• Operational efficiency gains: Newly appointed COO Jeff Rowe emphasized progress in reducing unplanned downtime, modernizing facilities, and expanding automation, which contributed to higher global crush volumes and improved production reliability.
• Nutrition recovery and challenges: The Nutrition segment saw operating profit growth, especially in Flavors and Animal Nutrition. However, management cited ongoing challenges, including inflationary input costs, unplanned plant downtime, and continued market softness in certain product lines such as wholesome ingredients.
• Portfolio actions and joint ventures: ADM announced a joint venture with CJ to strengthen its amino acid supply chain, aiming to improve cost competitiveness and reliability for feed-grade amino acids amid global market pressures.
• Capital allocation discipline: Management reduced capital expenditure guidance, prioritizing high-return projects like debottlenecking domestic crush and ethanol facilities, while also resuming opportunistic share repurchases and maintaining a selective approach to M&A.

Drivers of future performance

ADM’s guidance reflects expectations for sustained biofuels demand, ongoing cost controls, and targeted growth investments, balanced by macroeconomic uncertainties.

• Biofuels and regulatory landscape: Management anticipates the constructive biofuels environment—driven by robust demand, policy incentives, and strong soybean oil and meal markets—to continue supporting segment profits, though they acknowledged that market volatility and policy shifts remain ongoing risks.
• Nutrition segment outlook: The company expects continued growth in Flavors and Animal Nutrition, with recovery from recent plant downtime and operational improvements. However, management flagged seasonally lower volumes and persistent inflationary cost pressures as headwinds for the near term.
• Technology and operational investments: Ongoing automation, digitization, and R&D initiatives are projected to enhance efficiency and support long-term earnings growth, while disciplined capital allocation is expected to maintain flexibility for future opportunities and manage interest rate exposure.

Catalysts in upcoming quarters

In the coming quarters, the StockStory team will be monitoring (1) the sustainability of biofuels-driven margins amid evolving policy and market conditions, (2) the pace of recovery and growth in Nutrition, particularly as key plants ramp up and new joint ventures launch, and (3) the execution of cost-saving and automation initiatives that management believes will underpin future profitability. Results from voluntary carbon initiatives and precision fermentation projects will also serve as important signposts for longer-term value creation.

Archer-Daniels-Midland currently trades at $70.70, down from $75.77 just before the earnings. Is there an opportunity in the stock? The answer lies in our full research report (it’s free).

Now could be the perfect time to invest in these stocks

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.